Motilal Oswal picked ten Diwali stocks, including Symbiotec Pharmalab, for potential gains up to 40%. Symbiotec Pharmalab has a target price of Rs 1,430 against its current market price of Rs 1,168. This shows a potential upside of 22%. Many investors look for such growth opportunities during the festive season period.

Symbiotec Pharmalab has a target price of Rs 1,430 against its current market price of Rs 1,168, indicating a potential upside of 22%. Its EPS is projected to grow at a CAGR of 23% between FY26 and FY28E, while FY27E RoE is estimated at 10.4%.